SEARCH

SEARCH BY CITATION

reference

  • 1
    Anonymous (1993) A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 329:987994.
  • 2
    Baiocchi, RA, Caligiuri, MA (1994) Low-dose interleukin 2 prevents the development of Epstein-Barr virus (EBV)-associated lymphoproliferative disease in scid/scid mice reconstituted i.p. with EBV-seropositive human peripheral blood lymphocytes. Proc Natl Acad Sci U S A 91:55775581.
  • 3
    Batiuk, TD, Barry, JM, Bennett, WM, Meyer, MM, Tolzman, D, Norman, DJ (1993) Incidence and type of cancer following the use of OKT3: a single center experience with 557 organ transplants. Transplant Proc 25:1391.
  • 4
    Blanche, S, Le Deist, F, Veber, F, Lenoir, G, Fischer, AM, Brochier, J, Boucheix, C, Delaage, M, Griscelli, C, Fischer, A (1988) Treatment of severe Epstein-Barr virusinduced polyclonal B-lymphocyte proliferation by anti-B-cell monoclonal antibodies. Two cases after HLA-mismatched bone marrow transplantation. Ann Intern Med 108:199203.
  • 5
    Carbone, PP, Kaplan, HS, Musshoff, K, Smithers, DW, Tubiana, M (1971) Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 31:18601861.
  • 6
    Cleary, ML, Nalesnik, MA, Shearer, WT, Sklar, J (1988) Clonal analysis of transplant-associated lymphoproliferations based on the structure of the genomic termini of the Epstein-Barr virus. Blood 72:349352.
  • 7
    Cohen, JI (1991) Epstein-Barr virus lymphoproliferative disease associated with acquired immunodeficiency. Medicine (Baltimore) 70:137160.
  • 8
    Fischer, A, Blanche, S, Le Bidois, J, Bordigoni, P, Garnier, JL, Niaudet, P, Morinet, F, Le Deist, F, Fischer, AM, Griscelli, C, et al. (1991) Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation. N Engl J Med 324:14511456.
  • 9
    Frizzera, G, Hanto, DW, Gajl Peczalska, KJ, Rosai, J, McKenna, RW, Sibley, RK, Holahan, KP, Lindquist, LL (1981) Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients. Cancer Res 41:42624279.
  • 10
    Gruber, SA, Skjei, KL, Sothern, RB, Robison, L, Tzardis, P, Moss, A, Gillingham, K, Canafax, DM, Matas, AJ, Dunn, DL (1991) Cancer development in renal allograft recipients treated with conventional and cyclosporine immunosuppression. Transplant Proc 23:11041105.
  • 11
    Hanto, DW, Frizzera, G, Gajl Peczalska, J, Purtilo, DT, Klein, G, Simmons, RL, Najarian, JS (1981) The Epstein-Barr virus (EBV) in the pathogenesis of posttransplant lymphoma. Transplant Proc 13:756760.
  • 12
    Hanto, DW, Frizzera, G, Purtilo, DT, Sakamoto, K, Sullivan, JL, Saemundsen, AK, Klein, G, Simmons, RL, Najarian, JS (1981) Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of the Epstein-Barr virus. Cancer Res 41:42534261.
  • 13
    Hanto, DW, Frizzera, G, Gajl Peczalska, KJ, Sakamoto, K, Purtilo, DT, Balfour, HH, Jr, Simmons, RL, Najarian, JS (1982) Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation. N Engl J Med 306:913918.
  • 14
    Hanto, DW, Gajl Peczalska, KJ, Frizzera, G, Arthur, DC, Balfour, HH Jr, McClain, K, Simmons, RL, Najarian, JS (1983) Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Clinical, pathologic, and virologic findings and implications for therapy. Ann Surg 198:356369.
  • 15
    Hanto, DW, Frizzera, G, Gajl Peczalska, KJ, Simmons, RL (1985) Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation. Transplantation 39:461472.
  • 16
    Harris, NL, Jaffe, ES, Diebold, J, Flandrin, G, Muller-Hermelink, HK, Vardiman, J, Lister, TA, Bloomfield, CD (2000) The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Mod Pathol 13:193207.
  • 17
    Ho, M, Jaffe, R, Miller, G, Breinig, MK, Dummer, JS, Makowka, L, Atchison, RW, Karrer, F, Nalesnik, MA, Starzl, TE (1988) The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation 45:719727.
  • 18
    Hoelzer, D, Thiel, E, Loffler, H, Bodenstein, H, Plaumann, L, Buchner, T, Urbanitz, D, Koch, P, Heimpel, H, Engelhardt, R (1984) Intensified therapy in acute lymphoblastic and acute undifferentiated leukemia in adults. Blood 64:3847.
  • 19
    Hummel, M, Anagnostopoulos, I, Dallenbach, F, Korbjuhn, P, Dimmler, C, Stein, H (1992) EBV infection patterns in Hodgkin's disease and normal lymphoid tissue: expression and cellular localization of EBV gene products. Br J Haematol 82:689694.
  • 20
    Khatri, VP, Baiocchi, RA, Bernstein, ZP, Caligiuri, MA (1997) Immunotherapy with low-dose interleukin-2: rationale for prevention of immune-deficiency-associated cancer. Cancer J Sci Am 3 [suppl 1]:S129136.
  • 21
    Khouri, IF, Romaguera, J, Kantarjian, H, Palmer, JL, Pugh, WC, Korbling, M, Hagemeister, F, Samuels, B, Rodriguez, A, Giralt, S, Younes, A, Przepiorka, D, Claxton, D, Cabanillas, F, Champlin, R (1998) Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma. J Clin Oncol 16:38033809.
  • 22
    Leblond, V, Sutton, L, Dorent, R, Davi, F, Bitker, MO, Gabarre, J, Charlotte, F, Ghoussoub, JJ, Fourcade, C, Fischer, A, et al. (1995) Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center. J Clin Oncol 13:961968.
  • 23
    Leblond, V, Davi, F, Charlotte, F, Dorent, R, Bitker, MO, Sutton, L, Gandjbakhch, I, Binet, JL, Raphael, M (1998). Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity J Clin Oncol 16:20522059.
  • 24
    List, AF, Greco, FA, Vogler, LB (1987) Lymphoproliferative diseases in immunocompromised hosts: the role of Epstein-Barr virus. J Clin Oncol 5:16731689.
  • 25
    Mathur, A, Kamat, DM, Filipovich, AH, Steinbuch, M, Shapiro, RS (1994) Immunoregulatory abnormalities in patients with Epstein-Barr virus-associated B cell lymphoproliferative disorders. Transplantation 57:10421045.
  • 26
    McKelvey, EM, Gottlieb, JA, Wilson, HE, Haut, A, Tallcy, RW, Stephens, R, Lane, M, Gamble, JF, Jones, SE, Grozea, PN, Gutterman, J, Coltman, C, Moon, TE (1976) hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma. Cancer 38:14841493.
  • 27
    Mihalov, ML, Gattuso, P, Abraham, K, Holmes, EW, Reddy, V (1996) Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center. Clin Transplant 10:248255.
  • 28
    Morrison, VA, Dunn, DL, Manivel, JC, Gajl Peczalska, KJ, Peterson, BA (1994) Clinical characteristics of post-transplant lymphoproliferative disorders. Am J Med 97:1424.
  • 29
    Nalesnik, MA, Rao, AS, Furukawa, H, Pham, S, Zeevi, A, Fung, JJ, Klein, G, Gritsch, HA, Elder, E, Whiteside, TL, Starzl, TE (1997) Autologous lymphokine-activated killer cell therapy of Epstein-Barr virus-positive and -negative lymphoproliferative disorders arising in organ transplant recipients. Transplantation 63:12001205.
  • 30
    Nalesnik, MA, Jaffe, R, Starzl, TE, Demetris, AJ, Porter, K, Burnham, JA, Makowka, L, Ho, M, Locker, J (1988) The pathology of posttransplant lymphoproliferative disorders occurring in the setting of Cyclosporin A prednisone immunosuppression. Am J Pathol 133:173192.
  • 31
    O'Brien, S, Bernert, RA, Logan, JL, Lien, YH (1997) Remission of posttransplant lymphoproliferative disorder after interferon alfa therapy. J Am Soc Nephrol 8:14831489.
  • 32
    Opelz, G (1996). Are post-transplant lymphomas inevitable Nephrol Dial Transplant 11:19521955.
  • 33
    Opelz, G, Henderson, R (1993) Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet 342:15141516.
  • 34
    Paiva, A, Freitas, L, Pratas, J, Gomes, H, Mota, A, Marques, A, Furtado, AL (1998) Post-transplant lymphoproliferative disease. Nephrol Dial Transplant 13:29682971.
  • 35
    Papadopoulos, EB, Ladanyi, M, Emanuel, D, Mackinnon, S, Boulad, F, Carabasi, MH, Castro Malaspina, H, Childs, BH, Gillio, AP, Small, TN, et al. (1994) Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N Engl J Med 330:11851191.
  • 36
    Pedagogos, E, Dowling, J, Rockman, S, Nicholls, K, Fraser, I, Walker, R (1996) Lymphoproliferative disorder post renal transplantation: recent experience at a single centre. Nephrology 2:133141.
  • 37
    Penn, I (1988) Tumors of the immunocompromised patient. Annu Rev Med 39:6373.
  • 38
    Penn, I (1990) Cancers complicating organ. N Engl J Med 323:17671769.
  • 39
    Penn, I, Brunson, ME (1988) Cancers after cyclosporine therapy. Transplant Proc 20:885892.
  • 40
    Seiden, MV, Sklar, J (1993) Molecular genetic analysis of post-transplant lymphoproliferative disorders. Hematol Oncol Clin North Am 7:447465.
  • 41
    Shapiro, RS, Chauvenet, A, McGuire, W, Pearson, A, Craft, AW, McGlave, P, Filipovich, A (1988) Treatment of B-cell lymphoproliferative disorders with interferon alfa and intravenous gamma globulin. N Engl J Med 318:1334.
  • 42
    Shapiro, RS, McClain, K, Frizzera, G, Gajl Peczalska, KJ, Kersey, JH, Blazar, BR, Arthur, DC, Patton, DF, Greenberg, JS, Burke, B (1988) Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood 71:12341243.
  • 43
    Smith, JL, Wilkinson, AH, Hunsicker, LG, Tobacman, J, Kapelanski, DP, Johnson, M, Wright, FH, Behrendt, DM, Corry, RJ (1989) Increased frequency of post-transplant lymphomas in patients treated with cyclosporine, azathioprine, and prednisone. Transplant Proc 21:31993200.
  • 44
    Starzl, TE, Nalesnik, MA, Porter, KA, Ho, M, Iwatsuki, S, Griffith, BP, Rosenthal, JT, Hakala, TR, Shaw, BW Jr, Hardesty, RL (1984) Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporinesteroid therapy. Lancet 1:583587.
  • 45
    Sullivan, JL, Byron, KS, Brewster, FE, Sakamoto, K, Shaw, JE, Pagano, JS (1982) Treatment of life-threatening Epstein-Barr virus infection with acyclovir. Am J Med 73:262266.
  • 46
    Swinnen, LJ (2000) Diagnosis and treatment of transplant-related lymphoma. Ann Oncol 11 [suppl 1]:4548.
  • 47
    Swinnen, LJ, Costanzo Nordin, MR, Fisher, SG, O'Sullivan, EJ, Johnson, MR, Heroux, AL, Dizikes, GJ, Pifarre, R, Fisher, RI (1990) Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients (comments). N Engl J Med 323:17231728.
  • 48
    Wilkinson, AH, Smith, JL, Hunsicker, LG, Tobacman, J, Kapeianski, DP, Johnson, M, Wright, FH, Behrendt, DM, Corry, RJ (1989) Increased frequency of posttranplant lymphomas in patients treated with cyclosporine, azathioprine, and prednisone. Transplantation 47:293296.
  • 49
    World Health Organization (1979) WHO handbook for reporting results of cancer teratment. WHO, Geneva